In nasopharyngeal carcinomas and ESCC LTBP2 expression is reduced and re-expression of LTBP2 in ESCC tumor cells suppresses neoplastic capacity in vitro and in vivo[13], [15]. The gene discussed is LTBP2; the disease is neoplasm.